General Information of the Compound
| Compound ID |
CP0390013
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[8-(benzylamino)-1,3-dimethyl-2,6-dioxopurin-7-yl]-N-[(E)-(2,3,4-trihydroxyphenyl)methylideneamino]butanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H27N7O6
|
||||||||||||||||||
| Molecular Weight |
521.534
|
||||||||||||||||||
| Canonical SMILES |
Cn1c2nc(NCc3ccccc3)n(CCCC(=O)N\N=C\c3ccc(O)c(O)c3O)c2c(=O)n(C)c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H27N7O6/c1-30-22-19(23(37)31(2)25(30)38)32(24(28-22)26-13-15-7-4-3-5-8-15)12-6-9-18(34)29-27-14-16-10-11-17(33)21(36)20(16)35/h3-5,7-8,10-11,14,33,35-36H,6,9,12-13H2,1-2H3,(H,26,28)(H,29,34)/b27-14+
Show/Hide
|
||||||||||||||||||
| InChIKey |
XHCLEDFUONOPHD-MZJWZYIUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01305, 3',5'-cyclic-AMP phosphodiesterase 4B
Protein ID: PT01728, High affinity 3',5'-cyclic-AMP phosphodiesterase 7A